The Effects of Mesenchymal Stem Cells on the Gene Expression of TGF-beta and IFN-gamma in Patients with Rheumatoid Arthritis

The therapeutic and immunomodulatory potential of mesenchymal stem cells (MSCs) in rheumatoid arthritis (RA) has attracted considerable scientific attention in recent decades. This study aimed to evaluate the expression of genes encoding interleukin (IL)4 and IL10, as well as interferon-gamma (IFNG...

Full description

Bibliographic Details
Main Authors: Maryam Rahimi Khorashad, Mohsen Ghoryani, Arezoo Gowhari Shabgah, Zhaleh Shariati-Sarabi, Jalil Tavakkol Afshari, Mojgan Mohammadi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2023-04-01
Series:Iranian Journal of Allergy, Asthma and Immunology
Subjects:
Online Access:https://ijaai.tums.ac.ir/index.php/ijaai/article/view/3633
_version_ 1827922255142715392
author Maryam Rahimi Khorashad
Mohsen Ghoryani
Arezoo Gowhari Shabgah
Zhaleh Shariati-Sarabi
Jalil Tavakkol Afshari
Mojgan Mohammadi
author_facet Maryam Rahimi Khorashad
Mohsen Ghoryani
Arezoo Gowhari Shabgah
Zhaleh Shariati-Sarabi
Jalil Tavakkol Afshari
Mojgan Mohammadi
author_sort Maryam Rahimi Khorashad
collection DOAJ
description The therapeutic and immunomodulatory potential of mesenchymal stem cells (MSCs) in rheumatoid arthritis (RA) has attracted considerable scientific attention in recent decades. This study aimed to evaluate the expression of genes encoding interleukin (IL)4 and IL10, as well as interferon-gamma (IFNG) and transforming growth factor beta (TGFB1) in refractory RA patients following intravenous injection of autologous bone marrow-derived MSCs (BM-MSCs). This study was registered in Iranian Registry of Clinical Trials (IRCT) (2015102824760N1) and ClinicalTrials.gov (identifier: NCT03333681). Blood samples were taken from 13 patients before and 1 and 6 months after the MSC injection to evaluate the clinical manifestations, paraclinical factors, and expression of IL4, IL10, IFNG, and TGFB1 genes employing the SYBR Green real-time reverse-transcriptase polymerase chain reaction (RT-PCR) technique. There was a significant increase in the expression of TGFB1 at 1 and 6 months after the MSC injection compared to that in the baseline, while the expression of IL4 and IL10 did not change significantly. On the other hand, the expression of IFNG increased significantly after 1 month but decreased significantly at 6 months compared to 1 month after the intervention. Nevertheless, it showed no significant decrease compared to the baseline. A significant decrease was observed for the expression of IFNG 6 months after the injection compared to that after 1 month, which was in concordance with the rise in the expression of the TGFB1 gene. A significant change in the gene expression of TGFB1 and IFNG in our study was consistent with the amelioration of clinical manifestations, suggesting a mechanism of action for MSCs in the treatment of RA.
first_indexed 2024-03-13T04:39:02Z
format Article
id doaj.art-1a3169abf9014995b0918767cd3f960e
institution Directory Open Access Journal
issn 1735-1502
1735-5249
language English
last_indexed 2024-03-13T04:39:02Z
publishDate 2023-04-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Allergy, Asthma and Immunology
spelling doaj.art-1a3169abf9014995b0918767cd3f960e2023-06-19T06:28:29ZengTehran University of Medical SciencesIranian Journal of Allergy, Asthma and Immunology1735-15021735-52492023-04-0122210.18502/ijaai.v22i2.12679The Effects of Mesenchymal Stem Cells on the Gene Expression of TGF-beta and IFN-gamma in Patients with Rheumatoid ArthritisMaryam Rahimi Khorashad0Mohsen Ghoryani1Arezoo Gowhari Shabgah2Zhaleh Shariati-Sarabi3Jalil Tavakkol Afshari4Mojgan Mohammadi5Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Laboratory Sciences, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran AND Research Center of Advanced Technologies in Medicine, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, IranSchool of Medicine, Bam University of Medical Sciences, Bam, IranRheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran AND Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IranImmunology Research Center, Mashhad University of Medical Sciences, Mashhad, IranImmunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran The therapeutic and immunomodulatory potential of mesenchymal stem cells (MSCs) in rheumatoid arthritis (RA) has attracted considerable scientific attention in recent decades. This study aimed to evaluate the expression of genes encoding interleukin (IL)4 and IL10, as well as interferon-gamma (IFNG) and transforming growth factor beta (TGFB1) in refractory RA patients following intravenous injection of autologous bone marrow-derived MSCs (BM-MSCs). This study was registered in Iranian Registry of Clinical Trials (IRCT) (2015102824760N1) and ClinicalTrials.gov (identifier: NCT03333681). Blood samples were taken from 13 patients before and 1 and 6 months after the MSC injection to evaluate the clinical manifestations, paraclinical factors, and expression of IL4, IL10, IFNG, and TGFB1 genes employing the SYBR Green real-time reverse-transcriptase polymerase chain reaction (RT-PCR) technique. There was a significant increase in the expression of TGFB1 at 1 and 6 months after the MSC injection compared to that in the baseline, while the expression of IL4 and IL10 did not change significantly. On the other hand, the expression of IFNG increased significantly after 1 month but decreased significantly at 6 months compared to 1 month after the intervention. Nevertheless, it showed no significant decrease compared to the baseline. A significant decrease was observed for the expression of IFNG 6 months after the injection compared to that after 1 month, which was in concordance with the rise in the expression of the TGFB1 gene. A significant change in the gene expression of TGFB1 and IFNG in our study was consistent with the amelioration of clinical manifestations, suggesting a mechanism of action for MSCs in the treatment of RA. https://ijaai.tums.ac.ir/index.php/ijaai/article/view/3633CytokinesImmunomodulationInflammationMesenchymal stem cellsRheumatoid arthritis
spellingShingle Maryam Rahimi Khorashad
Mohsen Ghoryani
Arezoo Gowhari Shabgah
Zhaleh Shariati-Sarabi
Jalil Tavakkol Afshari
Mojgan Mohammadi
The Effects of Mesenchymal Stem Cells on the Gene Expression of TGF-beta and IFN-gamma in Patients with Rheumatoid Arthritis
Iranian Journal of Allergy, Asthma and Immunology
Cytokines
Immunomodulation
Inflammation
Mesenchymal stem cells
Rheumatoid arthritis
title The Effects of Mesenchymal Stem Cells on the Gene Expression of TGF-beta and IFN-gamma in Patients with Rheumatoid Arthritis
title_full The Effects of Mesenchymal Stem Cells on the Gene Expression of TGF-beta and IFN-gamma in Patients with Rheumatoid Arthritis
title_fullStr The Effects of Mesenchymal Stem Cells on the Gene Expression of TGF-beta and IFN-gamma in Patients with Rheumatoid Arthritis
title_full_unstemmed The Effects of Mesenchymal Stem Cells on the Gene Expression of TGF-beta and IFN-gamma in Patients with Rheumatoid Arthritis
title_short The Effects of Mesenchymal Stem Cells on the Gene Expression of TGF-beta and IFN-gamma in Patients with Rheumatoid Arthritis
title_sort effects of mesenchymal stem cells on the gene expression of tgf beta and ifn gamma in patients with rheumatoid arthritis
topic Cytokines
Immunomodulation
Inflammation
Mesenchymal stem cells
Rheumatoid arthritis
url https://ijaai.tums.ac.ir/index.php/ijaai/article/view/3633
work_keys_str_mv AT maryamrahimikhorashad theeffectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT mohsenghoryani theeffectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT arezoogowharishabgah theeffectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT zhalehshariatisarabi theeffectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT jaliltavakkolafshari theeffectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT mojganmohammadi theeffectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT maryamrahimikhorashad effectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT mohsenghoryani effectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT arezoogowharishabgah effectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT zhalehshariatisarabi effectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT jaliltavakkolafshari effectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis
AT mojganmohammadi effectsofmesenchymalstemcellsonthegeneexpressionoftgfbetaandifngammainpatientswithrheumatoidarthritis